Plenary and Panel Speakers
Henning BOHN, is Professor of Economics at the University of California, Santa Barbara. He has served as consultant to the World Bank, the Federal Reserve, and other major government institutions. His scholarly research covers macroeconomics, public economic, and international economics, including publications on government debt, public pensions, the sustainability of budget deficits, intergenerational risk sharing, optimal taxation, and demographic change.
Professor Bohn studied economics and mathematics at the University of Mannheim, Germany, and he earned a PhD in Business from Stanford University under the guidance of Ben Bernanke. He was on the finance faculty at the Wharton School (University of Pennsylvania) before moving to Santa Barbara in 1992. He has served as Chair of the UCSB Academic Senate and as Trustee of the UCSB Foundation.
Guy COUGHLAN, USS. Guy Coughlanis the Chief Financial Risk Officer at Universities Superannuation Scheme, a UKdefined benefit pension plan with assets of £49 billion. Guy joined USS in 2015as a member of the executive team to head up the newly-created group riskfunction, with responsibility for solvency, funding and investment risks, aswell as operational and cyber risks.
Guy spent much of his career at J.P. Morganwhere he was a Managing Director and over 17 years held various roles including GlobalHead of Longevity Solutions, Global Head of ALM Advisory, and Co-head ofEuropean Pension Advisory. During histime at J.P. Morgan Guy advised pension plans, corporations and insurancecompanies on investment, risk management and ALM. He began in fixed incomeresearch and was a member of the pioneering RiskMetrics team, in which he ledthe design, development and marketing of the first general-purpose commercialvalue-at-risk system called FourFifteen. In 1999 he founded the Global ALMAdvisory group and set up J.P. Morgan's longevity business in 2007. In thisrole, Guy led the development of LifeMetrics, an open-source platform forlongevity risk management that included longevity models and indices. In 2008he was involved in executing the world's first longevity hedges using capitalmarkets swaps.
In 2011 Guyjoined Pacific Global Advisors, a business providing fiduciary management andadvisory services to US pension plans. He served as a member of the managementteam with responsibility for the Risk function, the Actuarial team, and the ALMfunction.
Guy played a central role in establishing theLife & Longevity Markets Association (LLMA), a cross-industry body set upto promote the market for longevity risk transfer, serving as the inauguralchairman of the LLMA's Technical Committee. In 2012 he served on the US Societyof Actuaries' Longevity Task Force.Guy has aDPhil (i.e., PhD) in physics from Oxford University, and also holds a BScdegree from the University of Western Australia and an MBA from Henley BusinessSchool in the UK.
André DE VRIES, Vice President, Business Development, EMEA, Global FinancialSolutions at RGA focuses on capital motivated reinsurance, including longevity.André was directly involved in the longevity transactions that RGA implementedfor Delta Lloyd in the Netherlands in 2014 and 2015. He is based in Amsterdamand has worked in the financial industry for more than 15 years.
He beganhis career at ABN AMRO Bank as a quantitative consultant analyzing pre-paymentrisk in mortgage portfolios and deriving replicating portfolios for savingsproducts. Subsequently, he joined the Credit Risk Modelling group heading theteam responsible for measuring counterparty credit exposure on derivativeportfolios. Thereafter, he moved to the investment bank as a member of theInsurance Solutions Group where André structured life insurance reservefinancing transactions in the US and Canada.
Andréstudied Econometrics at the University of Tilburg and Actuarial Science at theUniversity of Amsterdam.
Michel DENUIT, Louvain (Actuarial Science). Michel Denuit received a Master's degree in Mathematics, a Master's degree in Actuarial Science and a PhD degree in Statistics, all from ULB (Brussels, Belgium).
He devoted all his career to teaching and research in actuarial science, at UCL (Louvain-la-Neuve, Belgium) where he is professor in the Institute of Statistics, Biostatistics and Actuarial Science. He serves as Chairman of the UCL Master in Actuarial Science.
He has held several visiting appointments at universities and research institutes, including the Centre for Risk and Insurance Studies of the KULeuven (Leuven, Belgium), the Department of Actuarial Science of the University of Lausanne (Switzerland), the Institute for Finance and Insurance of the Lyon 1 University (ISFA, Lyon, France), and the National Institute of Statistics and Applied Economics of Rabat (INSEA, Rabat, Marocco).
He has done extensive research in the areas of mathematical risk theory and actuarial pricing. He specialized in applying advanced probabilistic and statistical methods to solve actuarial problems. In addition to his books devoted to P&C and health insurance, he co-authored “Modelling Longevity Dynamics for Pensions and Annuity Business “ with E. Pitacco, S. Haberman, and A. Olivieri (Oxford University Press, 2009) as well as “Construction de Tables de Mortalité Périodiques et Prospectives” with A. Delwarde (Collection Audit-Actuariat-Assurance, Economica, Paris, 2005).
He conducted several projects with major European (re)insurance companies and banks. He has served as Director of the UCL Institute of Statistics, as well as on several professional actuarial committees in Belgium and in the EU.
For a detailed CV and a list of publications, see http://www.uclouvain.be/michel.denuit
Mark FLINT is Head of ImpairedAnnuities at SCOR Global Life UK Branch, where he is leading SCOR’s entry intothe UK enhanced annuity market. He was previously Director of Longevityat Munich Re UK Life Branch.
Mark did a MechanicalEngineering Degree at Southampton University. He then switched careers and qualified as a Fellow of the Institute of Actuaries in 1996. After several years as an adviser to pension scheme trustees and sponsoringemployers Mark went abroad, working in Chicago and Hong Kong.
Mark has worked in the UK LifeReinsurance market for fifteen years, specialising in longevity business since2007.
Serge GUERIN, ESG Paris, is a Sociologist and Professor at the Paris School of Business. Serge Guérinteaches in the MSc. program in Silver Economy at IEP Paris. Research associateat the Edgar Morin Centre ( EHESS / CNRS ), he also leads the Social InnovationFund of the Federation of Social Housing Enteprises.
Expert on ageing and intergenerational issues, he defends the need for apolicy of care and social assistance. In this context, Serge Guerin hascontributed to the emergence of the volunteer caregivers category in the publicspace.
He has authored twenty books, and has just published Silver Génération, 10 idées faussessur les seniors (Silver generation, 10 misconceptions about seniors), Michalon, 2015.
Denis JACQUAT is Member of French Parliament (Député)of the Moselle since 1986. He is a member of the Social Affairs Commission inthe National Assembly in France.
Recognized expert in the social field, he was, formany years reviewer of the Old-Age Insurance budget within the PLFSS (projectof law of social security financing in France) and is PLFSS reviewer for the2015 workers' compensation - occupational diseases.He serves on the Social Affairs Committee, Health andSustainable Development Council of Europe. He is also member of the Board of the Pensions (COR)and has chaired the Supervisory Board of CNAV.
Otolarngologist, Denis Jacquat is also very interested in the health, sport and disability area.
Amy KESSLER is senior vice president and head of Longevity RiskTransfer within Prudential's Pension Risk Transfer business. In thisrole, Amy leads Prudential’s longevity reinsurance business globally and serveson the senior leadership team for Prudential’s pension risk transfer efforts inthe United States. In 2011, Amy led Prudential's successful launch of itslongevity reinsurance product and, together with her exceptional team, hasclosed more than $37 billion in international reinsurance transactions since,covering members of nearly 200 pension funds in the United Kingdom, includingBritish Airways and Rolls Royce. In 2014, Amy led Prudential’sreinsurance team in the largest and most innovative longevity risk transfertransaction on record for the BT Pension Scheme – this transaction wasrecognized as Deal of the Year by Risk Magazine and earned Prudential tophonors as Reinsurer of the Year. With more than 25 years ofexperience, Amy is an innovator whose work helps pension funds proactivelymanage longevity risk and create retirement security for their members.
Tom KIRKWOOD is Professor and Distinguished Research Fellow at Newcastle University, where he directed the Institute for Ageing and Health from 2004-2011. His research is on the science of ageing and on how genetic and non-genetic factors, such as nutrition, influence longevity and health in old age. He is an elected Fellow of the UK Academy of Medical Sciences and of the Royal College of Physicians of Edinburgh and an Honorary Fellow of the Faculty and Institute of Actuaries. He advises a range of national and international organizations on the opportunities and challenges of population ageing. He has published many research papers, won several international prizes for his research, and is a frequent contributor to television, radio and newspapers. His books include the award-winning ‘Time of Our Lives: The Science of Human Ageing’, ‘Chance, Development and Ageing’, ‘The End of Age’ based on his BBC Reith Lectures in 2001, and ‘An Age of Wonders: the Story of the Newcastle 85+ Study’
Ronald LEE is a demographerand economist, with an MA in Demography from Berkeley and a Ph.D. in Economicsfrom Harvard. Since 1979 he has been at the University of California atBerkeley, currently as a Professor of the Graduate School, and FoundingDirector (Emeritus) of the Center for the Economics and Demography of Aging. Heis also a Research Associate of the NBER. Throughout his career, he has taughteconomic demography. With Carter he developed the Lee-Carter method formodeling and forecasting mortality which is now widely used in government andfinance. He currently co-chairs a committee of the National Academy of Sciencesthat is analyzing the increasing inequality in life expectancy by economicstatus in the United States and the implications of this trend for theprogressivity of the major public programs for the elderly, including pensions,health care and long term care.
His current research focuses on the macroeconomicconsequences of changing population age distributions and on intergenerationaltransfers and population aging. He co-directs with Andrew Mason the NationalTransfer Accounts project (NTA), which currently includes collaborating researchteams in 47 countries. The project estimates intergenerational flows ofresources by age through the public and private sectors (NTAccounts.org), withapplications to the consequences of population aging, the demographic dividendsrealized during the demographic transition, fiscal stability of public andprivate transfer programs, the interrelation of public and private transferprograms and many other topics. NTA is now expanding to include gender and homeproduction. He also continues to work on modeling and forecasting demographic variablesincluding mortality (he is co-author of the Lee-Carter model) and onevolutionary biodemography. For five years he has co-chaired the NationalAcademy of Sciences Committee on the Long-run Macroeconomic Effects of theAging U.S. Population.
He is an elected member of the US National Academy ofSciences, American Association for the Advancement of Science, American Academyof Arts and Sciences, the American Philosophical Society, and a CorrespondingFellow of the British Academy. He is past President of the PopulationAssociation of America, and recipient of the Mindel C. Sheps Award for researchin Mathematical Demography, the Irene B. Taeuber Award for outstanding contributionsin the field of demography, and an Honorary Doctorate, honoris causa,from Lund University, Sweden. He has served on both the National AdvisoryCommittee on Aging (NIA Council) and the National Advisory Committee on ChildHealth and Human Development (NICHD Council).
Jean-HervéLORENZI, Major at the Agrégation des facultés de droit etsciences economies (Faculties of Law and Economics) in 1975, is Chairman of theCercle des économistes (the famous circle of French economists), holder of the Chair“Demographic Transition, Economic Transition within the Fondation du Risque (Foundationof the Risk) and Chairman of the Pôle de Compétitivité (Pole of Competitiveness)“Finance Innovation”. He is a member of the Board of Directors of the Edmond deRothschild France Group, of the supervisory board of Euler Hermes and the Boardsof directors (board meetings) of the Médéric Alzheimer Foundation, the IDATEand the BNP Paribas Cardif. He was Professor at the university Paris-Dauphineand the member of council of economic analysis. He has notably published: Un monde de violences. L'économie mondiale2015-2030, Paris, Eyrolles, 2014 ; Rajeunissementet vieillissement de la France (with J. Pelletan and A. Villemeur), Paris,Descartes & Cie, 2012 ; Droitecontre gauche, (with O. Pastré), Paris, Fayard, 2012 ; Le fabuleux destin d'une puissanceintermédiaire, Paris, Grasset, 2011 ; Le choc des populations : guerre ou paix, (in collaboration with P.Dockès), Paris, Fayard, 2010.
Jessica MOSHER is a policy analyst in the PrivatePension Unit of the OECD and co-author of the OECD publication on MortalityAssumptions and Longevity Risk along with Mr. Pablo Antolin. In addition to herwork on longevity risk, she is involved in topics relating to annuity productsand the regulation of insurer and pension fund investment. She has previousexperience working in risk management for an international insurance companywhere she was mainly responsible for developing the global modelling of mortalityand longevity risks under Solvency II. She was also involved in the Life andLongevity Markets Association (LLMA) and its work on basis risk for index-basedlongevity swaps. Ms. Mosher is a Fellow of the Society of Actuaries, holds aBachelors degree in Economics from the Wharton School of the University ofPennsylvania and is a candidate for a Masters degree in Behavioural Sciencefrom the London School of Economics and Political Science.
Avery MICHAELSON is a Vice President in theInsurance & Pension Solutions team at Société Générale. In this rolehe is working to develop a large and liquid market for trading longevity riskglobally, and has created innovative reinsurance and capital market solutionsthat provide clients with a powerful risk and capital management tool. Over his career, Mr. Michaelson has held various roles in the insurance-linkedsecurities and reinsurance markets – consistently focusing on longevity andmortality risks. Previously he worked at Coventry Capital, a leader inthe Life Settlement industry; and began his career at Deutsche Bank in theLongevity Derivatives Group. He graduated Magna Cum Laude with a BS inFinance from The Wharton School at the University of Pennsylvania.
RagnarNORBERG, born in 1945, is a Norwegian statisticianand actuary. His academic career started at the University of Oslo, where heobtained his two MSc degrees (cand.act and cand.real) and his doctorate (Dr.philos)and was recruited as an Assistant Professor in 1972. He was Professor of Statisticswith Insurance Mathematics at the University of Oslo (1984-1990), Professor ofInsurance Mathematics at the University of Copenhagen (1991-2000), and Professorof Statistics at the London School of Economics from 2000 (Emeritus since 2010).After retirement he was a full time Research Officer (Chercheur) at theUniversity of Lyon 1 for four years (2011-2014). In between he has beenemployed full time as Research Officer at Storebrand Insurance (1980-1981), GuestProfessor at ETH Zuerich (1981-1982) and the University of Melbourne (1998), hehas taught courses at the University of Strasbourg and the Free University ofBrussels, and he has paid longer visits to a number of academic institutions includingMoscow State University, Stanford University, and the University of the Aegean.He is elected member of the International Statistical Institute, Honorarymember of the Institute of Actuaries, Honorary member (Socio Corrispondente) ofthe Istituto Italiano degli Attuari, and Honorary Doctor of Science at Heriot-WattUniversity, Edinburgh. His research addresses a broad range of topics in risktheory, insurance mathematics (life, non-life, and credibility theory), financialmathematics, and related areas in statistics and probability. He is well knownin the international scientific and professional communities as a writer, anorganizer of conferences, an editor of academic journals, and a speaker in a longlist of major conferences, academic departments, and learned societies aroundthe world. Personal homepage is at http://isfa.univ-lyon1.fr/~norberg withlinks to full cv and selected publications.
Professeur(Full time Professor) at Université Lyon 1 since September 2003,
Laboratoire de Sciences Actuarielle et Financière (équiped’accueil 2429)
1991–2012 Actuaire associé (Partneractuary) at WINTER & Associés
Since 2013 Partner Actuary at PRIM’ACT
– HDR in actuarial sciences
– PhD Thesis, in actuarial sciences
Research interests: Solvency II (Pillars 1 and 2), IFRS,MCEV : internal models, ORSA quantitative models, market consistent valuations,economic scenario generators (both risk-neutral and historical views) -Modeling censored and truncated data (mortality, disability, lapse, etc.) :bestestimate assumptions for reserve calculations, longevity risk evaluation,catastrophic risk in life insurance - Stochastic models and simulationtechniques : best estimate and SCR calculation, both in standard model andinternal model ; time optimization for Monte-Carlo methods. – Liabilities valorizationand asset-liability management in life insurance.
E-mail: firstname.lastname@example.org Web: http://www.ressources-actuarielles.net
Jean-Michel RICARD, Association Siel Bleu. In 1997 Jean-Michel Ricard and Jean-Daniel MULLER completed their Masters in Sports Management at the college of Science and Technology in Physical and Sports Activities at the University of Strasbourg. However, Jean-Daniel and Jean-Michel didn’t wish to go into traditional teaching; rather, they decided to begin offering courses in Adapted Physical Activity for older people, with the aim both to provide preventative healthcare and to safeguard autonomy and independence.
As the organisation has developed, the beneficiaries of its work have expanded. Today, the organisation’s activities aim to provide life-long preventative healthcare and improved quality of life for children, pregnant women, senior citizens and the elderly as well as people with disabilities. The second objective of the organisation is to use APA as a complimentary therapy for people suffering from chronic illness such as cancer, diabetes, obesity, multiple sclerosis, Parkinson’s disease and more.
Today the 400 specialised graduates employed by the Groupe Associatif Siel Bleu provide services each week for more than 80,000 beneficiaries in France alone.
For more than 17 years the order of the day has been financial accessibility for all. This is why the Siel Bleu Foundation came to be.
Jean-Marie ROBINE is a Research Director at INSERM, the FrenchNational Institute of Health and Medical Research (http://www.inserm.fr), within the CERMES Research group in Paris and the Unit 1198 in Montpellier where he heads the research team Biodemography of longevity and vitality.He is also a Study Director at the advanced school Ecole pratique des hautes études (http://www.ephe.sorbonne.fr) in Paris. Hestudies human longevity, with the aim of understanding the relations betweenhealth and longevity. In particular, he measures the impact that the increasein adult life durations may have on the health status of the elderly population.
Since its creation in 1989, he has been thecoordinator of the International Networkon Health Expectancy (REVES), which brings together more some 100researchers worldwide (www.reves-network.org). He was the project leader of the European Joint Action EHLEIS(2011-2014) which provided analysis ofdisability-free life expectancies in the European Union (www.eurohex.eu). He is co-responsible for thedevelopment of the International Databaseon Longevity (IDL) in association with the Max Planck Institute forDemographic Research (Rostock) and INED (Paris). He is the project leader ofthe healthy longevity project granted by AXA Research Fund: the Five-Country Oldest Old Project (5-COOP).He is one of the Directors of the new French Research Consortium on ageing andlongevity (GDR CNRS 3662, 2014-2017).
Laurent SCHWARTZ, Ecole Polytechnique Paris (Oncology), is a Harvard trained medical oncologist. He is working at the Assistance Publique des Hôpitaux de Paris and at the Ecole Polytechnique. He is author of more than 200 peer reviewed publications and of several books. Despite huge investments and cost to the community,standardised cancer death rates (the number of death per 100 000 persons at agiven age) has not changed drastically, in the western world, in the past sixtyyears. For example despite the invention and diffusion of radical prostatectomy,radiation therapy, PSA screening and availability of new drugs, aggregate dataof death certificates demonstrate only a drop of 0,5% in prostate cancer deathrate since 1960.Cancer is probably a simple straightforward metabolicdisease. Cancer cells ingest large quantities of glucose than they cannot fullydigest resulting in cell division, increased pressure and metastatic spread.Accordingly, non expensive, already available drugs targeting the tumourmetabolism slow tumour growth in every murine tumour model. Metabolic treatmentof patients suffering from incurable metastatic disease delays tumourprogression and death. Treatment can be further improved using re-purposing ofother well known drugs such as metformin (antibiabetic), digoxin (heartdisease) or diclofenac (anti-inflammatory). It is probable that cancer deathrates will be improved. Clinical trials must be deregulated in order tofacilitate the use of old molecules with a well established safety profile. It is probable that the radical simplification of cancerbiology will have a profound impact on society.
Philip SIMPSON is a principal and consulting actuary in theLondon office of Milliman. Philip specializes in life insurance andreinsurance. His consulting assignments include longevity swaps,reinsurance, annuities, mergers and acquisitions, financial reporting, companyreconstructions, new company launches, and product design and pricing. Philiphad advised a wide variety of financial institutions on longevity relatedprojects including product pricing and design, reinsurance, securitisations andtransactions. Philip has advised buyers and purchasers on a large numberof mergers and acquisitions, including ones with significant longevityexposures. Prior to being a consultant, Philip worked in reinsurance,where his experience included design and review of reinsurance programs and awide range of annuity, life and health insurance products. Philip is a member of the UK actuarial profession’s Research Thought Leadership Committee and its Mortality Research SteeringCommittee. Philip has a BSc, Mathematics and Theoretical Physicsfrom St Andrews University and an MBA specializing in Financial Risk Managementfrom Edinburgh Business School.
Pierre-Henri TAVOILLOT is Maître de conférences in philosophy at Université Paris Sorbonne-Paris IV.He is president of the Collège de philosophie and co-director of the collection « Le Nouveau collège dephilosophie » published by Grasset.Previously, Pierre-Henri served as advisor at the cabinet of the Ministry ofEducation (2000-2002) and member of the Society Analysis Committee (referreingto the Prime Minister) from 2004 to 2013. He has written several books, andreceived the 2007 François Furet Award for his book Philosophie des âges dela vie, co-authored with Eric Deschavanne (Paris, Grasset, 2007; reed.Hachette Pluriel, 2008).
AlexZHAVORONKOV, PhD is the CEO of Insilico Medicine, Inc a Baltimore-based companyutilizing big data analysis and deep learning for aging research and drugdiscovery. He also heads the International Aging Research Portfolio (IARP)knowledge management system for aging research and serves as the chief scienceofficer of the Biogerontology Research Foundation in the UK.
Prior toInsilico Medicine, he co-founded the First Oncology Research and AdvisoryCenter (FORAC), served as the director of ATI Technologies (Nasdaq: AMD) and asthe director of GTCBio. Dr. Zhavoronkov is the author of over fortypeer-reviewed scientific as well as popular papers and books including “TheAgeless Generation: how biomedical advances will transform the global economy”published by Palgrave Macmillan. Heholds two bachelor degrees from Queen's University, a masters in biotechnologyfrom Johns Hopkins University and a PhD in physics and mathematics from theMoscow State University and is the international adjunct professor at theMoscow Institute of Physics and Technology.